These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25684663)

  • 1. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
    Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
    Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
    Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
    Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G
    Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
    Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation.
    Kim YH; Lee YJ
    J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover.
    Kim JH; Kim MJ; Choi KC; Son J
    Int J Biochem Cell Biol; 2016 Sep; 78():327-334. PubMed ID: 27477310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
    Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression.
    Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D
    Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
    Shrader M; Pino MS; Lashinger L; Bar-Eli M; Adam L; Dinney CP; McConkey DJ
    Cancer Res; 2007 Feb; 67(4):1430-5. PubMed ID: 17308080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells.
    Siegmund D; Klose S; Zhou D; Baumann B; Röder C; Kalthoff H; Wajant H; Trauzold A
    Cell Signal; 2007 Jun; 19(6):1172-84. PubMed ID: 17291719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
    Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.
    Llobet D; Eritja N; Yeramian A; Pallares J; Sorolla A; Domingo M; Santacana M; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
    Eur J Cancer; 2010 Mar; 46(4):836-50. PubMed ID: 20071162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells.
    Hwang MK; Min YK; Kim SH
    Biochem Cell Biol; 2009 Dec; 87(6):919-26. PubMed ID: 19935877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway.
    Chen Z; Sangwan V; Banerjee S; Chugh R; Dudeja V; Vickers SM; Saluja AK
    Cancer Lett; 2014 Jun; 348(1-2):156-66. PubMed ID: 24662747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
    Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
    Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
    Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
    Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.